The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
NCT00171431 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2012-04-20
Summary
Evaluation of the effect of tegaserod treatment on small intestinal motility and flow pattern in female IBS-C patients.
Conditions
- Constipation Predominant
- Irritable Bowel Syndrome (IBS-C)
Interventions
- DRUG
-
Tegaserod
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis · Novartis
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2006-05-31
- Completion
- 2006-05-31
Countries
- United States
Study Locations
More Related Trials
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel Syndrome
NCT00904696 ·Status: COMPLETED
-
A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679
NCT00511563 ·Status: WITHDRAWN ·Phase: PHASE2
-
Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome
NCT01139736 ·Status: COMPLETED ·Phase: PHASE4
-
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
NCT03125564 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Cognitive-Behaviour Therapy for Irritable Bowel Syndrome and the Gut Microbiome
NCT02313246 ·Status: TERMINATED ·Phase: NA
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome
NCT00659763 ·Status: COMPLETED
-
Intracolonic FODMAP Infusion in Healthy Volunteers
NCT06488534 ·Status: COMPLETED ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Confocal Laser Endomicroscopy in IBS Patients
NCT02313207 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Microbiota Transplantation for IBS
NCT05776914 ·Status: RECRUITING ·Phase: PHASE2
-
Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome
NCT01331213 ·Status: COMPLETED ·Phase: PHASE4
-
Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity
NCT05795049 ·Status: ACTIVE_NOT_RECRUITING
-
Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy
NCT01413945 ·Status: TERMINATED
-
Colonoscopic Probiotics Spray in Irritable Bowel Syndrome
NCT05864716 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
NCT04214470 ·Status: WITHDRAWN
-
Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease
NCT01966341 ·Status: WITHDRAWN ·Phase: NA
-
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NCT05097872 ·Status: RECRUITING ·Phase: NA
-
Microbiota Profiling in IBS
NCT03720314 ·Status: COMPLETED
-
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
NCT00067561 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome
NCT00135031 ·Status: COMPLETED ·Phase: PHASE3